| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/07/2010 | CA2728681A1 Adenine receptor ligands |
| 01/07/2010 | CA2728492A1 Treatment |
| 01/07/2010 | CA2727252A1 Isoindolone derivatives as mek kinase inhibitors and methods of use |
| 01/06/2010 | EP2141168A1 Heteroaryl derivatives |
| 01/06/2010 | EP2141166A1 Adenine receptor ligands |
| 01/06/2010 | EP2140881A1 Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists |
| 01/06/2010 | EP2139879A1 Quinoline derivatives for the treatment of inflammatory diseases |
| 01/06/2010 | EP2139875A2 Oxazolidine and morpholine carboxamide derivatives as p2x7 modulators |
| 01/06/2010 | EP2139865A1 Solid forms of (e) -1- (4- ( (ir, 2s, 3r) -1, 2, 3, 4-tetrahydroxybutyl) -1h-imidazol-2-yl) ethanone oxime |
| 01/06/2010 | EP2139858A1 Piperidinone carboxamide derivatives as p2x7 modulators |
| 01/06/2010 | EP2139851A2 Substituted amide derivatives |
| 01/06/2010 | EP2139847A1 Novel quinonoid derivatives of cannabinoids and their use in the treatment of malignancies |
| 01/06/2010 | EP2139836A1 Perfluoroketone compounds and uses thereof |
| 01/06/2010 | EP2139504A1 Standardized bioactive herbal extracts |
| 01/06/2010 | EP2139331A1 Compositions and methods relating to novel compounds and targets thereof |
| 01/06/2010 | EP2139328A2 Hexahydro-cycloheptapyrazole cannabinoid modulators |
| 01/06/2010 | EP2139327A1 Method for treating cb2 receptor mediated pain |
| 01/06/2010 | EP2139326A1 Method for treating cb2 receptor mediated pain |
| 01/06/2010 | EP1891029B1 Organic compounds for the treatment of imflammatory or alleric conditions |
| 01/06/2010 | EP1513831B1 Novel compounds, their use and preparation |
| 01/06/2010 | EP0963197B1 Guanylhydrazones useful for treating diseases associated with t cell activation |
| 01/06/2010 | CN100577681C Compounds, compositions and methods for treatment of inflammatory diseases and conditions |
| 01/06/2010 | CN100577677C Caulis trachelospermi total lignans extractive, extraction method and medicine use of the active constituent thereof |
| 01/06/2010 | CN100577633C CaSR antagonist |
| 01/06/2010 | CN100577194C Powder medicine for treating hyperosteogeny |
| 01/06/2010 | CN100577191C Ointment for treating bone diseases and its preparing method |
| 01/06/2010 | CN100577182C Emulsion containing aucklandia root oil, its preparation process and use |
| 01/06/2010 | CN100577181C Extraction of herbs by heating alcohol |
| 01/06/2010 | CN100577180C Application of gambogicacid in preparing medication for restraining angiogenesis |
| 01/06/2010 | CN100577176C Extractive of Chinese globeflower in short petal, effective content of anti inflammation and usage |
| 01/06/2010 | CN100577170C Application of pyrazolopyrimidine Src family tyrosine kinase inhibitor in preparing medicament for curing myocardial infarction |
| 01/06/2010 | CN100577165C Medicinal composition for treating cold wet numbness and preparation method thereof |
| 01/06/2010 | CN100577154C Effervescence tablet of 'Shuang Huanglian' and its preparation process thereof |
| 01/06/2010 | CN100577144C Topical formulation for prevention and treatment of acne |
| 01/05/2010 | US7642903 Trailer tire alert system |
| 01/05/2010 | US7642351 2,4-Pyrimidinediamine compounds and their uses |
| 01/05/2010 | US7642345 Polynucleotides encoding human cytokine receptor |
| 01/05/2010 | US7642289 Drugs for chronic pain |
| 01/05/2010 | US7642276 N-[4-methyl-3-(3-piperidin-4-yl-1,2-benzisoxazol-6-yl)phenyl]-2-pyrrolidin-1-ylisonicotinamide; rheumatoid arthritis |
| 01/05/2010 | US7642261 Treating bipolar disorder, mania, dementia, sexual dysfunction, eating disorders, fibromyalgia |
| 01/05/2010 | US7642252 Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compositions and uses thereof |
| 01/05/2010 | US7642243 Administering C-type natriuretic peptide, guanyl cyclase (GC-B)-activating peptide |
| 01/05/2010 | US7641901 Immunotherapy of autoimmune disorders using antibodies which target B-cells |
| 01/05/2010 | US7641899 Methods for inhibiting IL-TIF-induced proliferation of hematopoietic cells using the cytokine receptor Zcytor16 |
| 01/05/2010 | US7641894 Stimulating neutrophil function to treat inflammatory bowel disease |
| 01/05/2010 | CA2570474C A combination composition comprising paracetamol and ibuprofen |
| 01/05/2010 | CA2473503C Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 01/05/2010 | CA2465723C Process for reacting alkaloids and use of the reaction products in the preparation of medicaments |
| 01/05/2010 | CA2456183C Il-6/ds-sil-6r fusion protein |
| 01/05/2010 | CA2449098C Pharmaceutical compositions for the coordinated delivery of nsaids |
| 01/05/2010 | CA2426467C Composition comprising 8-prenylnaringenin for treatment of skin |
| 01/05/2010 | CA2426457C Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 01/05/2010 | CA2424512C Delivery system and method of treating or preventing otitis media |
| 01/05/2010 | CA2405796C Methods and compositions for modulating alpha adrenergic receptor activity |
| 01/05/2010 | CA2392081C Pharmaceutically active isoindoline derivatives |
| 01/05/2010 | CA2185397C Arylalkyl-diazinones |
| 12/31/2009 | US20090326069 Azelaic acid ester compositions and methods for diagnosing and treating tissue conditions using azelaic acid ester compositions and proteinaceous biomarkers |
| 12/31/2009 | US20090326058 CaSR Antagonist |
| 12/31/2009 | US20090326038 Method for treating a immunology-related disease |
| 12/31/2009 | US20090326026 Tricyclic Compounds Useful as Angiotensin II Agonists |
| 12/31/2009 | US20090326000 Resveratrol formulations and methods of use |
| 12/31/2009 | US20090325995 Mixing a water-insoluble opioid, a water-soluble carrier, and a solvent for each of the opioid and the carrier; spray-drying the mixture to remove the solvent and obtain a substantially solvent-free nanodispersion of the opioid; in the carrier; oral administration; drug delivery |
| 12/31/2009 | US20090325982 Phosphodiesterase 4 inhibitors |
| 12/31/2009 | US20090325975 Use of compounds binding to the sigma receptor for the treatment of diabetes-associated pain |
| 12/31/2009 | US20090325962 Tyrosine derivative |
| 12/31/2009 | US20090325952 Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors |
| 12/31/2009 | US20090325933 Pyrimidinone Derivatives and Their Use as a Drug |
| 12/31/2009 | US20090325931 Use of cdk inhibitors for the treatment of granulocyte mediated disorders |
| 12/31/2009 | US20090325925 Thiophenes and uses thereof |
| 12/31/2009 | US20090325880 Tnf receptor-like molecules and uses thereof |
| 12/31/2009 | US20090325876 Use of lipid conjugates in the treatment of diseases associated with vasculature |
| 12/31/2009 | US20090325869 Synthetic regulators of ferritin protein nanocage pores and methods of use thereof |
| 12/31/2009 | US20090324647 Albumin-Free Botulinum Toxin Based Pharmaceutical Compositions Containing a Hyaluronidase and Methods of Use |
| 12/31/2009 | US20090324646 Targeting the Histone Code as a Bacterial Strategy for Selectively Modulating Gene Expression |
| 12/31/2009 | US20090324599 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity |
| 12/31/2009 | US20090324598 Method for the treatment of inflammatory disorders |
| 12/31/2009 | US20090324588 Treating Inflammatory Disorders With Antibodies to the Alpha-7 Nicotinic Receptors |
| 12/31/2009 | DE102008002685A1 Verfahren zur Herstellung eines Arzneimittels auf pflanzlicher Basis A process for preparing a pharmaceutical composition based on plants |
| 12/30/2009 | WO2009158719A2 Methods and compositions for treating disorders |
| 12/30/2009 | WO2009158571A1 Heteroaryl compounds and uses thereof |
| 12/30/2009 | WO2009158446A2 Crystalline forms of ((((4-((5-(cyclopropylcarbamoyl)-2-methylphenyl)amino)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl)carbonyl)(propyl)carbamoyl)oxy)methyl (4-(phosphonooxy)phenyl)acetate, method of preparation and use thereof |
| 12/30/2009 | WO2009158426A1 6-substituted phenoxychroman carboxylic acid derivatives |
| 12/30/2009 | WO2009158380A1 Cyclopentathiophene modulators of the glucocorticoid receptor, ap-1, and/or nf-kappa b activity and use thereof |
| 12/30/2009 | WO2009158031A2 Methods and compositions for therapeutic treatment |
| 12/30/2009 | WO2009158026A1 Hydrazonamide compounds that modulate hsp90 activity |
| 12/30/2009 | WO2009157515A1 Pharmaceutical compositions |
| 12/30/2009 | WO2009156161A1 Pharmaceutical compositions comprising aminoadamantane derivatives |
| 12/30/2009 | WO2009135673A3 Compounds with glycidic structure active in the therapy of systemic and local inflammation |
| 12/30/2009 | WO2009117831A9 Hybrid molecules having mixed vitamin d receptor agonism and histone deacetylase inhibitory properties |
| 12/30/2009 | WO2009112678A3 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 12/30/2009 | WO2009106748A3 Derivatives of n-phenyl-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
| 12/30/2009 | WO2009106708A3 Azetidine derivatives, their preparation and their application in therapy |
| 12/30/2009 | EP2138482A1 Bicyclic heterocyclic compound |
| 12/30/2009 | EP2138174A1 Pharmaceutical composition in the form of a sublingual tablet consisting of a non-steroidal anti-inflammatory agent and an opiate analgesic for pain management |
| 12/30/2009 | EP2138173A1 Pharmaceutical compositions comprising aminoadamantane derivatives |
| 12/30/2009 | EP2137193A2 Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof |
| 12/30/2009 | EP2137186A1 Heterocyclic compounds and their uses |
| 12/30/2009 | EP2137165A1 Inhibitors of protein kinases |
| 12/30/2009 | EP2137164A1 Inhibitors of protein kinases |
| 12/30/2009 | EP2137163A1 Inhibitors of protein kinases |